Muscle wasting and cachexia in heart failure: mechanisms and therapies.
about
Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure.Casting the net broader to confirm our imaginations: the long road to treating wasting disorders.Cardiac cachexia in sub-Saharan Africa.Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).Therapeutic considerations of sarcopenia in heart failure patients.Wasting away: How to treat cachexia and muscle wasting in chronic disease?Muscle wasting and sarcopenia in heart failure and beyond: update 2017.Cardiac Cachexia - A Window to the Wasting DisordersCardiac cachexia: perspectives for prevention and treatmentSkeletal muscle aging: influence of oxidative stress and physical exerciseCancer-induced muscle wasting: latest findings in prevention andMicroRNAs in muscle wasting and cachexia induced by heart failure.Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.Role of microRNAs in wasting in heart failure.Current Evidence about Nutrition Support in Cardiac Surgery Patients-What Do We Know?Proteomic profiling of skeletal and cardiac muscle in cancer cachexia: alterations in sarcomeric and mitochondrial protein expression.Chemotherapy-induced muscle wasting: an update.Whey protein supplementation for the preservation of mass and muscular strength of patients with heart failure: study protocol for a randomized controlled trial
P2860
Q47108632-9C208450-26B1-4674-8686-3041CB667659Q47132964-3A65DA83-8C01-4F2A-A948-278A94002196Q47415856-3B248C6B-9E88-4801-9F0F-25159A53C355Q47625103-36B0F4BB-1AD4-411B-BB2D-9B4A5B362C47Q47747144-E78A243E-95B3-49E6-BF40-30B2C24B91C9Q48743369-E21F8B7E-9D40-45DE-8875-1D3BF53B7147Q49183956-383E1E14-1537-438F-80DC-25DB94D6928AQ51763185-847D54B8-B674-49B9-85F1-E6AF7E578335Q51805704-B7CB149F-E6C1-453A-89BD-A77DCC9F7FB0Q52575994-1D9D3311-8CA3-4F2E-84B6-D0BD30C7D812Q52836641-736CE71C-CB05-4678-AAE6-FD92AD230962Q55014964-1CFCD24D-2D4E-4A15-8576-7E0CCDA44BDEQ55311011-E04A3234-0EA4-43E1-8762-10E0C41767E1Q55483337-4D7BB787-BD72-4D4D-97E6-C6CC897A19DFQ58795766-66DF0EA7-A6C5-4B22-A674-26DDD5F71661
P2860
Muscle wasting and cachexia in heart failure: mechanisms and therapies.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Muscle wasting and cachexia in heart failure: mechanisms and therapies.
@ast
Muscle wasting and cachexia in heart failure: mechanisms and therapies.
@en
Muscle wasting and cachexia in heart failure: mechanisms and therapies.
@nl
type
label
Muscle wasting and cachexia in heart failure: mechanisms and therapies.
@ast
Muscle wasting and cachexia in heart failure: mechanisms and therapies.
@en
Muscle wasting and cachexia in heart failure: mechanisms and therapies.
@nl
prefLabel
Muscle wasting and cachexia in heart failure: mechanisms and therapies.
@ast
Muscle wasting and cachexia in heart failure: mechanisms and therapies.
@en
Muscle wasting and cachexia in heart failure: mechanisms and therapies.
@nl
P2093
P2860
P356
P1476
Muscle wasting and cachexia in heart failure: mechanisms and therapies.
@en
P2093
Jochen Springer
Marcelo R Dos Santos
Nicole Ebner
P2860
P304
P356
10.1038/NRCARDIO.2017.51
P407
P577
2017-04-24T00:00:00Z